Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence

Georgios Nikolaidis; Alexis Llewellyn; Laetitia Helene Marie Schmitt; Nick Meader; Simon Mark Walker; Melissa Harden; Claire Rothery; Alison Jane Eastwood

Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence

Georgios Nikolaidis, Alexis Llewellyn, Laetitia Helene Marie Schmitt, Nick Meader, Simon Mark Walker, Melissa Harden, Claire Rothery, Alison Jane Eastwood

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health Research (NIHR)
Publication status	Published - 2021

Access to Document

https://www.nice.org.uk/guidance/ta710/documents/committee-papers-2

Cite this

Nikolaidis, G., Llewellyn, A., Schmitt, L. H. M., Meader, N., Walker, S. M., Harden, M., Rothery, C., & Eastwood, A. J. (2021). Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ta710/documents/committee-papers-2

@book{8e4dc06572a9457ba1b26ef79fe2f802,

title = "Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence",

author = "Georgios Nikolaidis and Alexis Llewellyn and Schmitt, {Laetitia Helene Marie} and Nick Meader and Walker, {Simon Mark} and Melissa Harden and Claire Rothery and Eastwood, {Alison Jane}",

year = "2021",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

Nikolaidis, G , Llewellyn, A , Schmitt, LHM , Meader, N , Walker, SM, Harden, M, Rothery, C & Eastwood, AJ 2021, Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence. National Institute for Health and Care Excellence. <https://www.nice.org.uk/guidance/ta710/documents/committee-papers-2>

TY - BOOK

T1 - Ravulizumab for atypical Haemolytic Uremic Syndrome

T2 - Evidence Review Group Report for the National Institute for Health and Care Excellence

AU - Nikolaidis, Georgios

AU - Llewellyn, Alexis

AU - Schmitt, Laetitia Helene Marie

AU - Meader, Nick

AU - Walker, Simon Mark

AU - Harden, Melissa

AU - Rothery, Claire

AU - Eastwood, Alison Jane

PY - 2021

Y1 - 2021

M3 - Commissioned report

BT - Ravulizumab for atypical Haemolytic Uremic Syndrome

PB - National Institute for Health and Care Excellence

ER -